Streetbeat News

Price Targets

AON

Wells Fargo analyst Elyse Greenspan has downgraded Aon (NYSE:AON) from Equal-Weight to Underweight and lowered the price target from $317 to $304.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:41 am

DDOG

Baird analyst William Power has downgraded Datadog (NASDAQ:DDOG) from Outperform to Neutral and lowered the price target from $100 to $84.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:35 am

NWE

Wells Fargo analyst Jonathan Reeder has upgraded NorthWestern Energy Group (NASDAQ:NWE) from Equal-Weight to Overweight and lowered the price target from $59 to $51.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:27 am

GOLF

Compass Point analyst Casey Alexander has upgraded Acushnet Hldgs (NYSE:GOLF) from Neutral to Buy and announced a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:25 am

ABBV

Barclays analyst Carter Gould has upgraded AbbVie (NYSE:ABBV) from Equal-Weight to Overweight and raised the price target from $160 to $170.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:17 am

MORN

Redburn Atlantic analyst Russell Quelch has upgraded Morningstar (NASDAQ:MORN) from Neutral to Buy and set a price target of $320.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:12 am

DLTR

Telsey Advisory Group analyst Joseph Feldman has reiterated an 'Outperform' rating on Dollar Tree (NASDAQ:DLTR) and maintained a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:03 am

CRSP

Needham analyst Gil Blum has reiterated a 'Buy' rating on CRISPR Therapeutics (NASDAQ:CRSP) and maintained an $88 price target.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 10:01 am

COST

Telsey Advisory Group analyst Joseph Feldman has reiterated an 'Outperform' rating on Costco Wholesale (NASDAQ:COST) and maintained a $600 price target.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 9:58 am

ARHS

Telsey Advisory Group analyst Joseph Feldman has reiterated his 'Outperform' rating on Arhaus (NASDAQ:ARHS), maintaining a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 9:52 am